Atreca News

Analysts Offer Insights on Healthcare Companies: Atreca (BCEL), Lucid Diagnostics (LUCD) and Vertex Pharmaceuticals (VRTX)

TipRanksNov 15, 2023 07:21 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: ALX Oncology Holdings (ALXO), Atreca (BCEL) and Sientra (SIEN)

TipRanksAug 15, 2023 22:10 ET

Wedbush Downgrades Atreca to Neutral, Lowers Price Target to $1

BenzingaAug 14, 2023 06:56 ET

Atreca Analyst Ratings

BenzingaAug 14, 2023 06:55 ET

Stifel Downgrades Atreca to Hold From Buy, Adjusts Price Target to $1 From $4

MT NewswiresAug 11, 2023 09:09 ET

Atreca Analyst Ratings

BenzingaAug 11, 2023 08:05 ET

Atreca (BCEL) Gets a Buy From H.C. Wainwright

TipRanksJun 5, 2023 06:35 ET

HC Wainwright & Co. Reiterates Buy on Atreca, Maintains $25 Price Target

BenzingaJun 5, 2023 06:17 ET

Stifel Adjusts Price Target on Atreca to $4 From $5, Maintains Buy Rating

MT NewswiresMay 11, 2023 11:40 ET

Stifel Maintains Buy on Atreca, Lowers Price Target to $4

BenzingaMay 11, 2023 10:41 ET

HC Wainwright & Co. Reiterates Buy on Atreca, Maintains $25 Price Target

BenzingaMay 11, 2023 06:42 ET

Atreca (BCEL) Gets a Buy From Wedbush

TipRanksMar 30, 2023 16:26 ET

The Latest Analyst Ratings for Atreca

BenzingaMar 30, 2023 16:03 ET

Stifel Nicolaus Adjusts Atreca Price Target to $5 From $10, Maintains Buy Rating

MT NewswiresMar 30, 2023 13:07 ET

Analysts' Top Healthcare Picks: Nemaura Medical (NMRD), Atreca (BCEL)

TipRanksMar 30, 2023 08:39 ET

Analysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX), Bluebird Bio (BLUE) and Atreca (BCEL)

TipRanksMar 30, 2023 06:41 ET

HC Wainwright & Co. Reiterates Buy on Atreca, Maintains $25 Price Target

BenzingaMar 30, 2023 06:28 ET

Evercore ISI Group Downgrades Atreca to In-Line, Lowers Price Target to $1.5

BenzingaMar 30, 2023 05:32 ET

Atreca (BCEL) Was Downgraded to a Hold Rating at Evercore ISI

TipRanksMar 30, 2023 04:26 ET

H.C. Wainwright Remains a Buy on Atreca (BCEL)

TipRanksFeb 7, 2023 07:31 ET